The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, multicenter, randomized, open-label study to evaluate the safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate-resistant prostate cancer (mCRPC).
 
Tie Zhou
No Relationships to Disclose
 
Dingwei Ye
No Relationships to Disclose
 
Zhongquan Sun
No Relationships to Disclose
 
Qinggui Meng
No Relationships to Disclose
 
Dalin He
No Relationships to Disclose
 
Guowei Shi
No Relationships to Disclose
 
Jie Jin
No Relationships to Disclose
 
Weibing Sun
No Relationships to Disclose
 
Lijun Chen
No Relationships to Disclose
 
Ben Liu
No Relationships to Disclose
 
Jingen Wang
No Relationships to Disclose
 
Jiwen Cheng
No Relationships to Disclose
 
Zhiquan Hu
No Relationships to Disclose
 
Yong Yang
No Relationships to Disclose
 
Xishuang Song
No Relationships to Disclose
 
Yinhuai Wang
No Relationships to Disclose
 
Cheng Fu
No Relationships to Disclose
 
Qiaoxia Zhou
Employment - Kintor Pharmaceutical
Leadership - Kintor Pharmaceutical
Stock and Other Ownership Interests - Kintor Pharmaceutical
Honoraria - Kintor Pharmaceutical
 
Youzhi Tong
Employment - Kintor Pharmaceutical
Leadership - Kintor Pharmaceutical
Stock and Other Ownership Interests - Kintor Pharmaceutical
Honoraria - Kintor Pharmaceutical
 
Ying-Hao Sun
No Relationships to Disclose